Back to Search
CHRISTIAN OCKENHOUSE, M.D.
M.D.
Infectious Disease Physician
NPI: 1639233851Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD045139L(PA)
Research & Publications (20)
Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells.
PMID 15897992·J Infect Dis·2005
8-other
Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax.
PMID 19138714·Vaccine·2009
7-preclinical
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.
PMID 19569965·J Infect Dis·2009
3-trial
Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.
PMID 19390585·PLoS One·2009
3-trial
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.
PMID 19649245·PLoS One·2009
3-trial
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya.
PMID 19262754·PLoS One·2009
3-trial
Report of a consultation on the optimization of clinical challenge trials for evaluation of candidate blood stage malaria vaccines, 18-19 March 2009, Bethesda, MD, USA.
PMID 19654061·Vaccine·2009
7-preclinical
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.
PMID 18387719·Vaccine·2008
3-trial
Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease.
PMID 18490697·Ann Intern Med·2008
5-case
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.
PMID 17442466·Vaccine·2007
3-trial
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.
PMID 17574311·Vaccine·2007
3-trial
Impact of antiretroviral treatment on gene expression in peripheral blood mononuclear cells from SIVmac251-infected macaques.
PMID 17597453·J Infect Dis·2007
7-preclinical
Advances in immunology and vaccine discovery report of the United States-European Commission workshop.
PMID 17728022·Vaccine·2007
8-other
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
PMID 17158893·Infect Immun·2007
7-preclinical
Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004.
PMID 17893312·Arch Intern Med·2007
8-other
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.
PMID 16388879·Vaccine·2007
3-trial
Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.
PMID 16356603·Vaccine·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6900 GEORGIA AVE NW, WRAMC BLDG 2 DEPARTMENT OF MEDICINE
WASHINGTON, DC 20307 - Phone
- (301) 319-9473
Quick Facts
- NPI
- 1639233851
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile